Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4.47 USD | -2.19% | -0.67% | +8.50% |
Apr. 17 | JonesTrading Starts Achieve Life Sciences With Buy Rating, $20 Price Target | MT |
Mar. 28 | Transcript : Achieve Life Sciences, Inc., Q4 2023 Earnings Call, Mar 28, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+8.50% | 157M | |
+1.08% | 42.86B | |
+12.10% | 42.74B | |
+44.30% | 41.36B | |
-6.20% | 27.68B | |
+6.54% | 25.15B | |
-23.61% | 18.63B | |
+28.48% | 12.37B | |
-2.85% | 11.92B | |
+7.12% | 11.21B |
- Stock Market
- Equities
- ACHV Stock
- News Achieve Life Sciences, Inc.
- Achieve Life Sciences Says Its Smoking Addiction Treatment Candidate Showed Better Quit Rates Than Placebo in Phase 3 Trial